Hemi-body radiotherapy in the management of metastatic carcinoma

Abstract

Hemi-body radiotherapy has been used extensively during the last 14 years to provide effective palliation for patients with widespread metastatic carcinoma. A series of 125 consecutive assessable treatments using this technique is reported. The morbidity was minimal. The response rate overall was 82% and a response rate of 85% was obtained in patients with carcinoma of the prostate.